Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Junci Investment

Founders Bing Jiang Liying Zhang

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$60M
Portfolio companies 18
Rounds per year 2.56
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Key employees Soon
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Machine Learning
  • Information Technology
  • Medical
  • Biotechnology

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Junci Investment:
Typical Co-investors
Junci Investment is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Junci Investment:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Singlera Genomics

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
$46M08 Jun 2022 San Diego, California, United States

Chinagene Tech

Clinical Trials
Enterprise
$15M30 Mar 2022 Changping District, Beijing, China

LeiShen Intelligent System

Hardware
Information Technology
Software
$46M29 Jul 2021 -

Geneplus-Beijing Co. Ltd.

Biotechnology
Health Diagnostics
$115M22 Jul 2021 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Junci Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 60M
Rounds per year 2.56
Peak activity year 2021
Lead investments 0
Follow on index 0.22
Group Appearance index 0.39

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Singlera Genomics

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
$46M08 Jun 2022 San Diego, California, United States

Chinagene Tech

Clinical Trials
Enterprise
$15M30 Mar 2022 Changping District, Beijing, China

LeiShen Intelligent System

Hardware
Information Technology
Software
$46M29 Jul 2021 -

Geneplus-Beijing Co. Ltd.

Biotechnology
Health Diagnostics
$115M22 Jul 2021 -
Crunchbase icon

Content report

The following text will be sent to our editors: